Cardiac Dimensions has announced the appointment of Gregory D Casciaro as president and chief executive officer (CEO), effective immediately. He will also become a member of Cardiac Dimensions’ board of directors. Casciaro has served in numerous executive leadership roles, most recently as the president and CEO of AccessClosure—an interventional cardiology medical device company that was acquired by Cardinal Health in 2014.
A press release reports that under the leadership of Casciaro, Cardiac Dimensions will continue to build on the success of its CE-marked, minimally invasive product, Carillon mitral contour system, which was specifically designed to treat functional (secondary) mitral regurgitation or functional mitral regurgitation in heart failure patients.
He says: “Cardiac Dimensions has an innovative platform that is designed to address the unmet needs of heart failure patients and the related condition of functional mitral regurgitation. The clinical data available for this therapy have demonstrated that it benefits patients significantly and, we believe, holds incredible promise for the future. I am excited to lead this talented team forward as we increase access to the therapy through continued global commercialisation and expanded clinical work.”
